| Author: Nanci Donacki |
| Source: Contributed by Nanci Donacki |
| Date Added: Tue May 14 2002 |
| Date Modified: Tue Apr 27 2004 |
Materials
DMEM, high glucose (Life Technologies, Inc. #10313-021 or equivalent)
Fetal Bovine Serum (Life Technologies, Inc. #16000-044 or equivalent)
L-glutamine (Life Technologies, Inc. #25030-149 or equivalent)
Hybridoma Cloning Factor (Fisher # IG50-0615)
50 ml sterile centrifuge tubes (Falcon #2070)
15 ml sterile centrifuge tubes (Falcon # 2099)
96 well culture plates (Falcon #3072))
Hemocytometer
Trypan Blue, 0.4% (Life Technologies, Inc. # 630-5150AG)
Multi-channel pipettor and sterile tips
Reagent Reservoir
HT (Life Technologies, Inc. #11067-030)
Procedure
The day before the cloning, refeed 24-well plates or flasks with fresh medium.
Prepare the cloning medium
DMEM
4 mM L-glutamine
20% FBS
10% Hybridoma Cloning Factor
Resuspend the cells to be cloned. Transfer 1 ml to a sterile 15 ml tube. Transfer 50 ml of this suspension to a clean tube for cell and viability counts.
Count the cells and determine the viability. NOTE: The viability must be greater than 80% to continue.
For each hybridoma cell line, calculate the dilutions to give 4 cells/ml, 2 cells/ml and 1 cell/ml in cloning medium.
Label 50 ml tubes for each clone and dilution.
Add medium to each tube according to the calculated dilutions.
Serially dilute each clone to 4, 2, and 1 cell/ml. The final dilution tube should contain 50 ml of cloning medium at 1 cell/ml.
Pour each of the dilutions into a sterile reagent reservoir. Plate 250 ml/well into 96-well plates - 1 plate at 4 cells/ml, 1 plate at 2 cells/ml and 2 plates at 1 cell/ml.
Complete dilutions and plating for each hybridoma cell line.
Place all plates at 37oC, 8-10% CO2. Incubate for 5-7 days.
Microscopically examine all plates to ensure cloning and plating efficiency before refeeding the plates.
2024年4月3日,北京——安捷倫科技公司(紐約證交所:A)近日宣布推出一套全新的自動化工作流程解決方案——高級稀釋系統AdvancedDilutionSystemADS2。該系統有助提高生產率,降低......
蛋白質作為構成人體組織器官的支架和主要物質,在人體生命活動中起著重要作用。蛋白質的相互作用能產生許多效應,如形成特異底物作用通道、生成新的結合位點、失活、作用底物專一性和動力學變化等,細胞的代謝、信號......
2021年9月9日,無錫臻和生物科技有限公司(以下簡稱“臻和科技”)與美國VyantBio公司簽署TissueofOrigin?(以下簡稱“TOO?”)全球權益和ZL轉讓協議,全資收購這款唯一獲FDA......
2021年7月20日,JournalofCellularPhysiology及JournalofCellularBiochemistry同時撤回了中國學者49篇文章。從2019年開始,Journalo......
磷酸甘油酸突變酶1(PGAM1)通過其代謝活性以及與其他蛋白質(例如α平滑肌肌動蛋白(ACTA2))的相互作用,在癌癥代謝和腫瘤進展中起關鍵作用。變構調節被認為是發現針對PGAM1的高選擇性和有效抑制......
2018年12月6日,來自圣迭戈的消息——Illumina公司(納斯達克股票代碼:ILMN)今天宣布推出新型高密度基因分型芯片Infinium?GlobalDiversityArray。這款芯片設計源......
SDS-PAGE異常電泳現象及分析SDS-PAGEHallofShame.pdf 很不錯的東東~~推薦下~......
Preparationofdenaturing6%polyacrylamidegelsformicrosatelliteanalysis(alsoforSSAP,high-resolutionIRAP......